Niels Svenstrup,Klaus Bæk Simonsen,Lars Kyhn Rasmussen,Karsten Juhl,Morten Langgård,Kate Wen,Yazhou Wang
申请号：
US15089819
公开号：
US20160213674A1
申请日:
2016.04.04
申请国别(地区):
US
年份:
2016
代理人:
摘要：
This invention is directed to compounds, which are PDE9 enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of the compounds of formula (I). The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula (I). The present invention further provides a compound of formula (I) for use in a method of treating a subject suffering from a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a compound of formula (I).
